New Delhi, May 23 -- Sun Pharma share price declined more than 4% on Friday after the drug major reported its Q4 results. Sun Pharma shares fell as much as 4.86% to Rs.1,636.30 apiece on the BSE.

Sun Pharmaceutical Industries reported a consolidated net profit of Rs.2,154 crore in the fourth quarter of FY25, registering a decline of 19% from Rs.2,659 crore in the year ago period.

The company's revenue from operations in Q4FY25 increased 8% to Rs.12,959 crore from Rs.11,983 crore, year-on-year (YoY).

Sun Pharma's India formulation sales rose 13.6% YoY in Q4FY25 to Rs.4,213 crore, while US formulation sales came at $464 million, down 2.5%YoY during the quarter.

Global speciality sales increased 8.6% to $295 million, accounting for 19.9%...